v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - ARS ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES    
Net income (loss) for the period $ (272,543) $ 1,254,213
Adjustments to reconcile net income to net cash flows provided by operating activities    
Allowances deducted from assets 106,972 71,823
Depreciation of PP&E 1,017,916 933,214
Amortization of intangible assets 153,773 106,453
Amortization of rights of use assets 190,881 185,262
Depreciation of Investment properties 1,557  
Disposals of Fixed and intangible assets 28,231 1,345
Earnings (losses) from associates and joint ventures 4,073 10,783
Financial results and others 643,891 (2,214,923)
Income tax expenses (64,409) 556,137
Income tax paid (10,892) (8,764)
Change in operating assets and liabilities, net of effects from purchase of controlled entity    
Increase Trade receivables (201,862) (247,512)
Increase Other receivables (45,457) (72,872)
Decrease Inventories 53,391 279
Decrease Trade payables (90,145) (15,384)
(Decrease) / Increase Salaries and social security payables (3,655) 52,355
(Decrease) / Increase Other taxes payables (232,403) 30,337
(Decrease) / Increase Other Liabilities and Provisions 17,058 (11,621)
Total cash flows from operating activities 1,296,377 631,125
CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES    
Payments for PP&E (688,580) (271,300)
Payments for intangible asset acquisitions (87,374) (39,380)
Dividends received from associates   1,229
Proceeds from the sale of PP&E and intangible assets 33,983 4,498
Payments for acquisition of subsidiary, net of cash acquired (1,209,041) (17,020)
Integration contributions in joint ventures (204)  
Compensation received for acquisition of companies   3,901
Proceeds from DFI liquidations 20,538 4,808
Proceeds from sale of investments not considered as cash and cash equivalents 281,163 330,941
Payments for investments not considered as cash and cash equivalents (416,138) (346,798)
Total cash flows used in investing activities (2,065,653) (329,121)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES    
Proceeds from borrowings 3,490,325 1,110,294
Payment of borrowings (2,273,464) (1,076,214)
Repurchase of Notes (13,917) (25,233)
Payment of interests, DFI and related expenses (307,055) (332,351)
Payments of leases liabilities (136,741) (76,631)
Dividends paid to non-controlling interests in subsidiaries (16,276) (11,713)
Total cash flows from (used in) financing activities 742,872 (411,848)
NET DECREASE IN CASH AND CASH EQUIVALENTS (26,404) (109,844)
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR 388,241 424,356
NET FOREIGN EXCHANGE DIFFERENCES AND RECPAM ON CASH AND CASH EQUIVALENTS 36,056 (73,647)
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD $ 397,893 $ 240,865